“I think we’re getting close to the point where my value add is more limited, and therefore I expect my activity to decrease gradually after Jan. 21, but as long as I’m asked, I will be helping,” Slaoui said Wednesday.
The decision to keep on Slaoui comes even as President-elect Joe Biden criticizes the Trump administration for the slow pace of vaccinations. Biden also recently announced plans to bring on a new team to help manage the Covid-19 response, including the inoculation effort. Some progressive lawmakers have also been critical of Slaoui’s drug industry ties.
Gen. Gustave Perna, OWS’ chief operating officer, said the Biden transition has not told him whether he will continue in his role.
“I’ve signed up, I’m here until my part of the mission is done or I’m told otherwise,” Perna said.
The Biden team did not immediately respond to a request for comment.